- Home
- FBIOP vs NOM Comparison
FBIOP vs NOM Comparison
Compare FBIOP & NOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- NOM
- Stock Information
- Founded
- FBIOP N/A
- NOM 1993
- Country
- FBIOP United States
- NOM United States
- Employees
- FBIOP 101
- NOM N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- NOM Investment Managers
- Sector
- FBIOP Health Care
- NOM Finance
- Exchange
- FBIOP Nasdaq
- NOM Nasdaq
- Market Cap
- FBIOP N/A
- NOM N/A
- IPO Year
- FBIOP N/A
- NOM N/A
- Fundamental
- Price
- FBIOP $6.61
- NOM $10.70
- Analyst Decision
- FBIOP
- NOM
- Analyst Count
- FBIOP 0
- NOM 0
- Target Price
- FBIOP N/A
- NOM N/A
- AVG Volume (30 Days)
- FBIOP N/A
- NOM 6.9K
- Earning Date
- FBIOP N/A
- NOM 01-01-0001
- Dividend Yield
- FBIOP N/A
- NOM 3.39%
- EPS Growth
- FBIOP N/A
- NOM N/A
- EPS
- FBIOP N/A
- NOM N/A
- Revenue
- FBIOP N/A
- NOM N/A
- Revenue This Year
- FBIOP N/A
- NOM N/A
- Revenue Next Year
- FBIOP N/A
- NOM N/A
- P/E Ratio
- FBIOP N/A
- NOM N/A
- Revenue Growth
- FBIOP N/A
- NOM N/A
- 52 Week Low
- FBIOP N/A
- NOM $8.52
- 52 Week High
- FBIOP N/A
- NOM $10.48
- Technical
- Relative Strength Index (RSI)
- FBIOP 58.26
- NOM 56.86
- Support Level
- FBIOP $6.15
- NOM $10.18
- Resistance Level
- FBIOP $6.50
- NOM $10.94
- Average True Range (ATR)
- FBIOP 0.31
- NOM 0.28
- MACD
- FBIOP -0.02
- NOM 0.05
- Stochastic Oscillator
- FBIOP 75.37
- NOM 71.70
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.